Quick Answer
InspireMD, Inc. reported Diluted EPS of $0.76 per share (loss) for fiscal year 2025.
InspireMD, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.76 | +0.0% |
| 2024 | -$0.76 | +7.3% |
| 2023 | -$0.82 | +65.1% |
| 2022 | -$2.35 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.17 | -6.3% | +34.6% |
| June 30, 2025 | -$0.26 | -18.2% | -18.2% |
| March 31, 2025 | -$0.22 | -4.8% | -37.5% |
| September 30, 2024 | -$0.16 | -6.7% | +27.3% |
| June 30, 2024 | -$0.22 | +8.3% | -4.8% |
| March 31, 2024 | -$0.21 | +60.4% | -40.0% |
| September 30, 2023 | -$0.15 | +74.1% | +37.5% |
| June 30, 2023 | -$0.24 | +59.3% | +54.7% |
- InspireMD, Inc. showed an increase of +0.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2022–2025 period, InspireMD, Inc.’s diluted eps has grown by 67.7% (from $2.35 per share (loss) to $0.76 per share (loss)).
- The most recent figure is from InspireMD, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 18, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: